| Pulmonary function and radiological features 4 months after COVID-19: first results from the national prospective observational Swiss COVID-19 lung study SA Guler, L Ebner, C Aubry-Beigelman, PO Bridevaux, M Brutsche, ... European respiratory journal 57 (4), 2021 | 379 | 2021 |
| Medium throughput breathing human primary cell alveolus-on-chip model JD Stucki, N Hobi, A Galimov, AO Stucki, N Schneider-Daum, CM Lehr, ... Scientific reports 8 (1), 14359, 2018 | 145 | 2018 |
| The Lysophosphatidic Acid Receptor LPA1 Promotes Epithelial Cell Apoptosis after Lung Injury M Funke, Z Zhao, Y Xu, J Chun, AM Tager American journal of respiratory cell and molecular biology 46 (3), 355-364, 2012 | 128 | 2012 |
| Acute exacerbation of idiopathic pulmonary fibrosis: international survey and call for harmonisation M Kreuter, M Polke, SLF Walsh, J Krisam, HR Collard, N Chaudhuri, ... European respiratory journal 55 (4), 2020 | 84 | 2020 |
| Swiss recommendations for the follow-up and treatment of pulmonary long COVID M Funke-Chambour, PO Bridevaux, CF Clarenbach, PM Soccal, LP Nicod, ... Respiration 100 (8), 826-841, 2021 | 65 | 2021 |
| Serum metabolic profiling identified a distinct metabolic signature in patients with idiopathic pulmonary fibrosis–a potential biomarker role for LysoPC B Rindlisbacher, C Schmid, T Geiser, C Bovet, M Funke-Chambour Respiratory research 19, 1-12, 2018 | 54 | 2018 |
| Idiopathic pulmonary fibrosis: the turning point is now! M Funke, T Geiser Swiss medical weekly 145 (2122), w14139-w14139, 2015 | 52 | 2015 |
| Surfactant replacement therapy reduces acute lung injury and collapse induration-related lung remodeling in the bleomycin model L Steffen, C Ruppert, HG Hoymann, M Funke, S Ebener, C Kloth, ... American journal of physiology-lung cellular and molecular physiology 313 (2 …, 2017 | 47 | 2017 |
| Idiopathic Pulmonary Fibrosis in Switzerland: Diagnosis and Treatment: Position Paper of the Swiss Working Group for Interstitial and Rare Lung Diseases of the Swiss … M Funke-Chambour, A Azzola, D Adler, C Barazzone-Argiroffo, C Benden, ... Respiration 93 (5), 363-378, 2017 | 40 | 2017 |
| Human microvasculature-on-a chip: anti-neovasculogenic effect of nintedanib in vitro S Zeinali, CA Bichsel, N Hobi, M Funke, TM Marti, RA Schmid, OT Guenat, ... Angiogenesis 21, 861-871, 2018 | 36 | 2018 |
| Azithromycin has enhanced effects on lung fibroblasts from idiopathic pulmonary fibrosis (IPF) patients compared to controls K Krempaska, S Barnowski, J Gavini, N Hobi, S Ebener, C Simillion, ... Respiratory research 21 (1), 1-16, 2020 | 34 | 2020 |
| Hypersensitivity pneumonitis secondary to lovebirds: a new cause of bird fancier's disease M Funke, JM Fellrath European Respiratory Journal 32 (2), 517-521, 2008 | 34 | 2008 |
| Safety and efficacy of pirfenidone and nintedanib in patients with idiopathic pulmonary fibrosis and carrying a telomere-related gene mutation A Justet, D Klay, R Porcher, V Cottin, K Ahmad, MM Molina, H Nunes, ... European respiratory journal 57 (2), 2021 | 33 | 2021 |
| Human-Based Advanced in vitro Approaches to Investigate Lung Fibrosis and Pulmonary Effects of COVID-19 M Kiener, N Roldan, C Machahua, A Sengupta, T Geiser, OT Guenat, ... Frontiers in medicine 8, 644678, 2021 | 31 | 2021 |
| The spike gene is a major determinant for the SARS-CoV-2 Omicron-BA. 1 phenotype GT Barut, NJ Halwe, A Taddeo, JN Kelly, J Schön, N Ebert, L Ulrich, ... Nature Communications 13 (1), 5929, 2022 | 29 | 2022 |
| Idiopathic pulmonary fibrosis—epidemiology, causes, and clinical course SC Schäfer, M Funke-Chambour, S Berezowska Der pathologe 41, 46-51, 2020 | 24 | 2020 |
| Lysophosphatidic acid signaling through the lysophosphatidic acid-1 receptor is required for alveolarization M Funke, L Knudsen, D Lagares, S Ebener, CK Probst, BA Fontaine, ... American journal of respiratory cell and molecular biology 55 (1), 105-116, 2016 | 24 | 2016 |
| Imaging in the aftermath of COVID-19: what to expect L Ebner, M Funke-Chambour, C von Garnier, G Ferretti, B Ghaye, ... European radiology 31, 4390-4392, 2021 | 23 | 2021 |
| Incidence and prognostic significance of hypoxemia in fibrotic interstitial lung disease: an international cohort study YH Khor, L Gutman, NA Hussein, KA Johannson, IN Glaspole, SA Guler, ... Chest 160 (3), 994-1005, 2021 | 22 | 2021 |
| Azithromycin for the treatment of chronic cough in idiopathic pulmonary fibrosis: a randomized controlled crossover trial SA Guler, C Clarenbach, M Brutsche, K Hostettler, AK Brill, A Schertel, ... Annals of the American Thoracic Society 18 (12), 2018-2026, 2021 | 18 | 2021 |
